Treatment Duration for Absence Epilepsy
Abstract
The effects of 6 months of treatment followed by a 5- to 6-week withdrawal period of ethosuximide (ESM) in 3 children, ages 5, 10, and 10 years, with new onset absence epilepsy are reported from the Departments of Neurology, State University of New York at Stony Brook, and the Division of Child Neurology, Schneider Children’s Hospital and Albert Einstein College of Medicine, New York.
DOI: https://doi.org/10.15844/pedneurbriefs-9-7-13 | Journal eISSN: 2166-6482
Language: English
Page range: 56 - 56
Published on: Jul 1, 1995
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 1995 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.